This page is available in multiple languages
Select Language

Euronext welcomes Genomic Vision on Euronext in Paris


Genomic Vision specializes in developing genetic diseases diagnosis tests and cancer genomic analysis. The group uses molecular combing technology which allows direct visualization of DNA individual molecules in order to detect the quantitative and qualitative changes of the genome and determine their role in targeted pathology.